Table 1. Live Attenuated Japanese Encephalitis Vaccine Consumption Value & CAGR: China VS Global, 2018-2029, US$ Million

Table 2. Live Attenuated Japanese Encephalitis Vaccine Market Restraints

Table 3. Live Attenuated Japanese Encephalitis Vaccine Market Trends

Table 4. Live Attenuated Japanese Encephalitis Vaccine Industry Policy

Table 5. Global Live Attenuated Japanese Encephalitis Vaccine Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022

Table 6. Global Live Attenuated Japanese Encephalitis Vaccine Revenue Share by Company, 2018-2023, Ranked by Data of 2022

Table 7. Global Live Attenuated Japanese Encephalitis Vaccine Sales Quantity by Company, (2018-2023) & (K Units), Ranked Based on Sales in 2022

Table 8. Global Live Attenuated Japanese Encephalitis Vaccine Sales Quantity by Company, 2018-2023, Ranked by Data of 2022

Table 9. Global Live Attenuated Japanese Encephalitis Vaccine Average Selling Price (ASP) by Company, (2018-2023) & (US$/Unit)

Table 10. Global Live Attenuated Japanese Encephalitis Vaccine Manufacturers Market Concentration Ratio (CR3 and HHI)

Table 11. Global Live Attenuated Japanese Encephalitis Vaccine Mergers & Acquisitions, Expansion Plans

Table 12. Global Live Attenuated Japanese Encephalitis Vaccine Manufacturers Product Type

Table 13. Head Office and Live Attenuated Japanese Encephalitis Vaccine Production Site of Key Manufacturer

Table 14. Live Attenuated Japanese Encephalitis Vaccine Capacity of Major Manufacturers and Future Plan

Table 15. China Live Attenuated Japanese Encephalitis Vaccine Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022

Table 16. China Live Attenuated Japanese Encephalitis Vaccine Sales Quantity by Company, (2018-2023) & (K Units), Ranked Based on Sales in 2022

Table 17. China Live Attenuated Japanese Encephalitis Vaccine Sales Quantity by Company, 2018-2023, Ranked by Data of 2022

Table 18. Global Live Attenuated Japanese Encephalitis Vaccine Production & Forecast by Region, 2018 VS 2022 VS 2029, (K Units)

Table 19. Global Live Attenuated Japanese Encephalitis Vaccine Production by Region, 2018-2023, (K Units)

Table 20. Global Live Attenuated Japanese Encephalitis Vaccine Production Forecast by Region, 2024-2029, (K Units)

Table 21. Global Key Players of Live Attenuated Japanese Encephalitis Vaccine Upstream (Raw Materials)

Table 22. Global Live Attenuated Japanese Encephalitis Vaccine Typical Customers

Table 23. Live Attenuated Japanese Encephalitis Vaccine Typical Distributors

Table 24. By Type, Global Live Attenuated Japanese Encephalitis Vaccine Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million

Table 25. By Application, Global Live Attenuated Japanese Encephalitis Vaccine Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million

Table 26. By Region, Global Live Attenuated Japanese Encephalitis Vaccine Consumption Value, 2018 VS 2022 VS 2029, US$ Million

Table 27. By Region, Global Live Attenuated Japanese Encephalitis Vaccine Consumption Value, 2018-2029, US$ Million

Table 28. By Region, Global Live Attenuated Japanese Encephalitis Vaccine Sales Quantity, 2018-2029, (K Units)

Table 29. By Country, Global Live Attenuated Japanese Encephalitis Vaccine Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million

Table 30. By Country, Global Live Attenuated Japanese Encephalitis Vaccine Consumption Value, 2018-2029, US$ Million

Table 31. By Country, Global Live Attenuated Japanese Encephalitis Vaccine Consumption Value Market Share, 2018-2029

Table 32. By Country, Global Live Attenuated Japanese Encephalitis Vaccine Sales Quantity, 2018-2029, (K Units)

Table 33. By Country, Global Live Attenuated Japanese Encephalitis Vaccine Sales Quantity Market Share, 2018-2029

Table 34. Novartis Company Information, Head Office, Market Area, and Industry Position

Table 35. Novartis Live Attenuated Japanese Encephalitis Vaccine Models, Specifications, and Application

Table 36. Novartis Live Attenuated Japanese Encephalitis Vaccine Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 37. Novartis Company Profile and Main Business

Table 38. Novartis Recent Developments

Table 39. Sanofi Company Information, Head Office, Market Area, and Industry Position

Table 40. Sanofi Live Attenuated Japanese Encephalitis Vaccine Models, Specifications, and Application

Table 41. Sanofi Live Attenuated Japanese Encephalitis Vaccine Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 42. Sanofi Company Profile and Main Business

Table 43. Sanofi Recent Developments

Table 44. Chengdu Institute of Biological Products Company Information, Head Office, Market Area, and Industry Position

Table 45. Chengdu Institute of Biological Products Live Attenuated Japanese Encephalitis Vaccine Models, Specifications, and Application

Table 46. Chengdu Institute of Biological Products Live Attenuated Japanese Encephalitis Vaccine Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 47. Chengdu Institute of Biological Products Company Profile and Main Business

Table 48. Chengdu Institute of Biological Products Recent Developments

Table 49. Wuhan Institute of Biological Products Company Information, Head Office, Market Area, and Industry Position

Table 50. Wuhan Institute of Biological Products Live Attenuated Japanese Encephalitis Vaccine Models, Specifications, and Application

Table 51. Wuhan Institute of Biological Products Live Attenuated Japanese Encephalitis Vaccine Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 52. Wuhan Institute of Biological Products Company Profile and Main Business

Table 53. Wuhan Institute of Biological Products Recent Developments

Table 54. Lanzhou Institute of Biological Products Company Information, Head Office, Market Area, and Industry Position

Table 55. Lanzhou Institute of Biological Products Live Attenuated Japanese Encephalitis Vaccine Models, Specifications, and Application

Table 56. Lanzhou Institute of Biological Products Live Attenuated Japanese Encephalitis Vaccine Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 57. Lanzhou Institute of Biological Products Company Profile and Main Business

Table 58. Lanzhou Institute of Biological Products Recent Developments

Table 59. Beijing Temple of Heaven Biological Products Company Information, Head Office, Market Area, and Industry Position

Table 60. Beijing Temple of Heaven Biological Products Live Attenuated Japanese Encephalitis Vaccine Models, Specifications, and Application

Table 61. Beijing Temple of Heaven Biological Products Live Attenuated Japanese Encephalitis Vaccine Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 62. Beijing Temple of Heaven Biological Products Company Profile and Main Business

Table 63. Beijing Temple of Heaven Biological Products Recent Developments

Table 64. Valneva Company Information, Head Office, Market Area, and Industry Position

Table 65. Valneva Live Attenuated Japanese Encephalitis Vaccine Models, Specifications, and Application

Table 66. Valneva Live Attenuated Japanese Encephalitis Vaccine Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 67. Valneva Company Profile and Main Business

Table 68. Valneva Recent Developments

Table 69. Bharat Biotech Company Information, Head Office, Market Area, and Industry Position

Table 70. Bharat Biotech Live Attenuated Japanese Encephalitis Vaccine Models, Specifications, and Application

Table 71. Bharat Biotech Live Attenuated Japanese Encephalitis Vaccine Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 72. Bharat Biotech Company Profile and Main Business

Table 73. Bharat Biotech Recent Developments

Table 74. Cheng Da Biology Company Information, Head Office, Market Area, and Industry Position

Table 75. Cheng Da Biology Live Attenuated Japanese Encephalitis Vaccine Models, Specifications, and Application

Table 76. Cheng Da Biology Live Attenuated Japanese Encephalitis Vaccine Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 77. Cheng Da Biology Company Profile and Main Business

Table 78. Cheng Da Biology Recent Developments

Table 79. Biocelect Pty Ltd Company Information, Head Office, Market Area, and Industry Position

Table 80. Biocelect Pty Ltd Live Attenuated Japanese Encephalitis Vaccine Models, Specifications, and Application

Table 81. Biocelect Pty Ltd Live Attenuated Japanese Encephalitis Vaccine Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 82. Biocelect Pty Ltd Company Profile and Main Business

Table 83. Biocelect Pty Ltd Recent Developments

Table 84. Glovax Co., Ltd. Company Information, Head Office, Market Area, and Industry Position

Table 85. Glovax Co., Ltd. Live Attenuated Japanese Encephalitis Vaccine Models, Specifications, and Application

Table 86. Glovax Co., Ltd. Live Attenuated Japanese Encephalitis Vaccine Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 87. Glovax Co., Ltd. Company Profile and Main Business

Table 88. Glovax Co., Ltd. Recent Developments

List of Figures

Figure 1. Live Attenuated Japanese Encephalitis Vaccine Picture

Figure 2. Global Live Attenuated Japanese Encephalitis Vaccine Consumption Value, (US$ million) & (2018-2029)

Figure 3. Global Live Attenuated Japanese Encephalitis Vaccine Sales Quantity, (K Units) & (2018-2029)

Figure 4. Global Live Attenuated Japanese Encephalitis Vaccine Average Selling Price (ASP), (2018-2029) & (US$/Unit)

Figure 5. China Live Attenuated Japanese Encephalitis Vaccine Consumption Value, (US$ million) & (2018-2029)

Figure 6. China Live Attenuated Japanese Encephalitis Vaccine Sales Quantity (K Units) & (2018-2029)

Figure 7. China Live Attenuated Japanese Encephalitis Vaccine Average Selling Price (ASP), (US$/Unit) & (2018-2029)

Figure 8. By Consumption Value, China Live Attenuated Japanese Encephalitis Vaccine Market Share of Global, 2018-2029

Figure 9. By Sales Quantity, China Live Attenuated Japanese Encephalitis Vaccine Market Share of Global, 2018-2029

Figure 10. Global Live Attenuated Japanese Encephalitis Vaccine Market Share by Company, (Tier 1, Tier 2, and Tier 3), 2022

Figure 11. China Live Attenuated Japanese Encephalitis Vaccine Key Participants, Market Share, 2022

Figure 12. Global Live Attenuated Japanese Encephalitis Vaccine Capacity, Production and Capacity Utilization, 2018-2029

Figure 13. Global Live Attenuated Japanese Encephalitis Vaccine Capacity Market Share by Region, 2022 VS 2029

Figure 14. Global Live Attenuated Japanese Encephalitis Vaccine Production Market Share & Forecast by Region, 2018-2029

Figure 15. Live Attenuated Japanese Encephalitis Vaccine Industry Chain

Figure 16. Live Attenuated Japanese Encephalitis Vaccine Procurement Model

Figure 17. Live Attenuated Japanese Encephalitis Vaccine Sales Model

Figure 18. Live Attenuated Japanese Encephalitis Vaccine Sales Channels, Direct Sales, and Distribution

Figure 19. 0.5ml

Figure 20. 1ml

Figure 21. 2.5ml

Figure 22. By Type, Global Live Attenuated Japanese Encephalitis Vaccine Consumption Value, 2018-2029, US$ Million

Figure 23. By Type, Global Live Attenuated Japanese Encephalitis Vaccine Consumption Value Market Share, 2018-2029

Figure 24. By Type, Global Live Attenuated Japanese Encephalitis Vaccine Sales Quantity, 2018-2029, (K Units)

Figure 25. By Type, Global Live Attenuated Japanese Encephalitis Vaccine Sales Quantity Market Share, 2018-2029

Figure 26. By Type, Global Live Attenuated Japanese Encephalitis Vaccine Average Selling Price (ASP), 2018-2029, (US$/Unit)

Figure 27. Hospital

Figure 28. Clinic

Figure 29. By Application, Global Live Attenuated Japanese Encephalitis Vaccine Consumption Value, 2018-2029, US$ Million

Figure 30. By Application, Global Live Attenuated Japanese Encephalitis Vaccine Consumption Value Market Share, 2018-2029

Figure 31. By Application, Global Live Attenuated Japanese Encephalitis Vaccine Sales Quantity, 2018-2029, (K Units)

Figure 32. By Application, Global Live Attenuated Japanese Encephalitis Vaccine Sales Quantity Market Share, 2018-2029

Figure 33. By Application, Global Live Attenuated Japanese Encephalitis Vaccine Average Selling Price (ASP), 2018-2029, (US$/Unit)

Figure 34. By Region, Global Live Attenuated Japanese Encephalitis Vaccine Consumption Value Market Share, 2018-2029

Figure 35. By Region, Global Live Attenuated Japanese Encephalitis Vaccine Sales Quantity Market Share, 2018-2029

Figure 36. North America Live Attenuated Japanese Encephalitis Vaccine Consumption Value & Forecasts, 2018-2029, US$ Million

Figure 37. By Country, North America Live Attenuated Japanese Encephalitis Vaccine Consumption Value Market Share, 2022

Figure 38. Europe Live Attenuated Japanese Encephalitis Vaccine Consumption Value & Forecasts, 2018-2029, US$ Million

Figure 39. By Country, Europe Live Attenuated Japanese Encephalitis Vaccine Consumption Value Market Share, 2022

Figure 40. Asia Pacific Live Attenuated Japanese Encephalitis Vaccine Consumption Value & Forecasts, 2018-2029, US$ Million

Figure 41. By Country/Region, Asia Pacific Live Attenuated Japanese Encephalitis Vaccine Consumption Value Market Share, 2022

Figure 42. South America Live Attenuated Japanese Encephalitis Vaccine Consumption Value & Forecasts, 2018-2029, US$ Million

Figure 43. By Country, South America Live Attenuated Japanese Encephalitis Vaccine Consumption Value Market Share, 2022

Figure 44. Middle East & Africa Live Attenuated Japanese Encephalitis Vaccine Consumption Value & Forecasts, 2018-2029, US$ Million

Figure 45. U.S. Live Attenuated Japanese Encephalitis Vaccine Sales Quantity, 2018-2029, (K Units)

Figure 46. By Type, U.S. Live Attenuated Japanese Encephalitis Vaccine Sales Quantity Market Share, 2022 VS 2029

Figure 47. By Application, U.S. Live Attenuated Japanese Encephalitis Vaccine Sales Quantity Market Share, 2022 VS 2029

Figure 48. Europe Live Attenuated Japanese Encephalitis Vaccine Sales Quantity, 2018-2029, (K Units)

Figure 49. By Type, Europe Live Attenuated Japanese Encephalitis Vaccine Sales Quantity Market Share, 2022 VS 2029

Figure 50. By Application, Europe Live Attenuated Japanese Encephalitis Vaccine Sales Quantity Market Share, 2022 VS 2029

Figure 51. China Live Attenuated Japanese Encephalitis Vaccine Sales Quantity, 2018-2029, (K Units)

Figure 52. By Type, China Live Attenuated Japanese Encephalitis Vaccine Sales Quantity Market Share, 2022 VS 2029

Figure 53. By Application, China Live Attenuated Japanese Encephalitis Vaccine Sales Quantity Market Share, 2022 VS 2029

Figure 54. Japan Live Attenuated Japanese Encephalitis Vaccine Sales Quantity, 2018-2029, (K Units)

Figure 55. By Type, Japan Live Attenuated Japanese Encephalitis Vaccine Sales Quantity Market Share, 2022 VS 2029

Figure 56. By Application, Japan Live Attenuated Japanese Encephalitis Vaccine Sales Quantity Market Share, 2022 VS 2029

Figure 57. South Korea Live Attenuated Japanese Encephalitis Vaccine Sales Quantity, 2018-2029, (K Units)

Figure 58. By Type, South Korea Live Attenuated Japanese Encephalitis Vaccine Sales Quantity Market Share, 2022 VS 2029

Figure 59. By Application, South Korea Live Attenuated Japanese Encephalitis Vaccine Sales Quantity Market Share, 2022 VS 2029

Figure 60. Southeast Asia Live Attenuated Japanese Encephalitis Vaccine Sales Quantity, 2018-2029, (K Units)

Figure 61. By Type, Southeast Asia Live Attenuated Japanese Encephalitis Vaccine Sales Quantity Market Share, 2022 VS 2029

Figure 62. By Application, Southeast Asia Live Attenuated Japanese Encephalitis Vaccine Sales Quantity Market Share, 2022 VS 2029

Figure 63. India Live Attenuated Japanese Encephalitis Vaccine Sales Quantity, 2018-2029, (K Units)

Figure 64. By Type, India Live Attenuated Japanese Encephalitis Vaccine Sales Quantity Market Share, 2022 VS 2029

Figure 65. By Application, India Live Attenuated Japanese Encephalitis Vaccine Sales Quantity Market Share, 2022 VS 2029

Figure 66. Middle East & Africa Live Attenuated Japanese Encephalitis Vaccine Sales Quantity, 2018-2029, (K Units)

Figure 67. By Type, Middle East & Africa Live Attenuated Japanese Encephalitis Vaccine Sales Quantity Market Share, 2022 VS 2029

Figure 68. By Application, Middle East & Africa Live Attenuated Japanese Encephalitis Vaccine Sales Quantity Market Share, 2022 VS 2029

Figure 69. Research Methodology

Figure 70. Breakdown of Primary Interviews

Figure 71. Bottom-up and Top-down Approaches

Figure 72. Top-down Approaches